RONDA HUISMAN: Open Payments
NPI 1194943449 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,323 in 16 payments from 8 companies in 2025. Trend: 2023 $1,972 · 2024 $1,231 · 2025 $1,323
Food & beverage: $1,323
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $339 |
| Teva Pharmaceuticals USA, Inc. | 3 | $305 |
| E.R. Squibb & Sons, L.L.C. | 2 | $195 |
| ABBVIE INC. | 4 | $153 |
| Janssen Pharmaceuticals, Inc | 1 | $135 |
| Neurocrine BioSciences, Inc. | 1 | $122 |
| Axsome Therapeutics, Inc. | 1 | $59 |
| Collegium Pharmaceutical, Inc. | 1 | $15 |
Products named: CAPLYTA, AUSTEDO XR, COBENFY, VRAYLAR, INVEGA SUSTENNA, INGREZZA, UZEDY, Auvelity.
Industry payments across TN — which companies pay providers there.
